C12Y 106/05009
Nadh:ubiquinone reductase
Official title: NADH:ubiquinone reductase (non-electrogenic) (1.6.5.9)
C12Y106/05009 (Nadh:ubiquinone reductase) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 8
- Assignees
- 8
- Inventors
- 28
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microorganisms and methods for increasing co-factors17 Mar 2026US 12,577,591 B2Genomatica, Inc.
- Compositions and methods for treating Leber's hereditary optic neuropathy7 Jun 2022US 11,352,645 B2Wuhan Neurophth Biotechnology Limited Company
- Yeast host cells for dicarboxylic acid production3 Aug 2021US 11,078,504 B2Dsm IP Assets B.V.
- Variants of yeast NDI1 gene, and uses thereof in the treatment of disease associated with mitochondrial dysfunction5 Mar 2019US 10,220,102 B2The Provost Fellows Foundation Scholars and the Other Members of Board of the College of the Hold and Undivided Trinity of Queen Elizabeth, Near Dublin Trinity College Dublin
- Acid-tolerant yeast cell, method of producing organic acid using the same, and method of producing the yeast cell21 Aug 2018US 10,053,714 B2Samsung Electronics Co., Ltd.
- Recombinant microorganism with regulated activity of manganese import protein and method for producing o-phosphoserine, cysteine or cysteine derivatives using the same6 Aug 2026US 2026/0226406 A1Cj Cheiljedang Corporation
- Recombinant microorganism in which expression of nadh:quinone oxidoreductase is controlled, and method for producing o-phosphoserine, cysteine, and derivative thereof by using same5 Sep 2024US 2024/0294955 A1Cj Cheiljedang Corporation
- Microorganisms and methods for increasing co-factors22 Dec 2022US 2022/0403420 A1Genomatica, Inc.
- Compositions and methods for treating leber's hereditary optic neuropathy18 Aug 2022US 2022/0259619 A1Wuhan Neurophth Biotechnology Limited Company
- Compositions and methods for treating leber's hereditary optic neuropathy24 Jun 2021US 2021/0189429 A1Wuhan Neurophth Biotechnology Limited Company
Most cited
By later US patents